Your browser doesn't support javascript.
loading
Impact of conditioning regimen intensity on outcomes of second allogeneic hematopoietic cell transplantation for secondary acute myelogenous leukemia.
Nagler, Arnon; Peczynski, Christophe; Dholaria, Bhagirathbhai; Labopin, Myriam; Valerius, Thomas; Dreger, Peter; Kröger, Nicolaus; Reinhardt, Hans Christian; Finke, Jürgen; Franke, Georg-Nikolaus; Ciceri, Fabio; Verbeek, Mareike; Blau, Igor Wolfgang; Bornhäuser, Martin; Spyridonidis, Alexandros; Bug, Gesine; Bazarbachi, Ali; Schmid, Christophe; Yakoub-Agha, Ibrahim; Savani, Bipin N; Mohty, Mohamad.
Afiliação
  • Nagler A; Division of Hematology, Sheba Medical Center, Tel Hashomer, Israel.
  • Peczynski C; ALWP of the EBMT Paris office, Paris, France.
  • Dholaria B; Vanderbilt University Medical Center, Nashville, TN, USA. Bhagirathbhai.r.dholaria@vumc.org.
  • Labopin M; Sorbonne University, Sevice d'hématologie Clinique et Thérapie Cellulaire, Hôpital Saint-Antoine, INSERM UMRs 938, Paris, France.
  • Valerius T; University Medical Center Schleswig Holstein, Campus Kiel, Section for Stem Cell Transplantation and Immunotherapy, Kiel, Germany.
  • Dreger P; University of Heidelberg, Medizinische Klinik u. Poliklinik V, Heidelberg, Germany.
  • Kröger N; University Hospital Eppendorf, Bone Marrow Transplantation Centre, Hamburg, Germany.
  • Reinhardt HC; University Duisburg-Essen, University Hospital Essen, Dept. of Bone Marrow Hematology and Stem Cell Transplantation, Essen, Germany.
  • Finke J; University of Freiburg, Dept. of Medicine -Hematology, Oncology, Freiburg, Germany.
  • Franke GN; Medical Clinic and Policinic 1, Hematology and Cellular Therapy, University Hospital Leipzig, Leipzig, Germany.
  • Ciceri F; Ospedale San Raffaele s.r.l., Haematology and BMT, Milano, Italy.
  • Verbeek M; Klinikum Rechts der Isar, III Med Klinik der TU, Munich, Germany.
  • Blau IW; Medizinische Klinik m. S. Hämatologie, Onkologie und Tumorimmunologie, Charité Universitätsmedizin, Berlin, Germany.
  • Bornhäuser M; Universitaetsklinikum Dresden, Medizinische Klinik und Poliklinik I, Dresden, Germany.
  • Spyridonidis A; Hematology Stem Cell Transplant Unit, School of Medicine, University of Patras, Patras, Greece.
  • Bug G; Department of Medicine 2, Hematology and Oncology, Goethe University Frankfurt, Frankfurt, Germany.
  • Bazarbachi A; Bone Marrow Transplantation Program, Department of Internal Medicine, American University of Beirut Medical Center, Beirut, Lebanon.
  • Schmid C; Department of Hematology and Oncology, University Hospital Augsburg, Augsburg, Germany.
  • Yakoub-Agha I; CHU de Lille, Univ Lille, INSERM, U1285, Lille, France.
  • Savani BN; Vanderbilt University Medical Center, Nashville, TN, USA.
  • Mohty M; Sorbonne University, Sevice d'hématologie Clinique et Thérapie Cellulaire, Hôpital Saint-Antoine, INSERM UMRs 938, Paris, France.
Bone Marrow Transplant ; 57(7): 1116-1123, 2022 07.
Article em En | MEDLINE | ID: mdl-35501565
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Leucemia Mieloide Aguda / Segunda Neoplasia Primária / Transplante de Células-Tronco Hematopoéticas / Doença Enxerto-Hospedeiro Idioma: En Ano de publicação: 2022 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Leucemia Mieloide Aguda / Segunda Neoplasia Primária / Transplante de Células-Tronco Hematopoéticas / Doença Enxerto-Hospedeiro Idioma: En Ano de publicação: 2022 Tipo de documento: Article